We Doctor
Stage
DivestitureTotal Raised
$1.936BInvestors Count
18Deal Terms
3Portfolio Exits
1Investments
4Funding, Valuation & Revenue
11 Fundings
We Doctor has raised $1.936B over 11 rounds.
We Doctor's latest funding round was a Series G for $150M on July 5, 2022.
We Doctor's valuation in February 2021 was $7,000M.
We Doctor's latest post-money valuation is from February 2021.
Sign up for a free demo to see We Doctor's valuations in May 2018 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
7/5/2022 | Series G | $150M | 3 | |||
2/25/2021 | Series F - II | $400M | HongShan, Millennium Management, and Undisclosed Investors | $7,000M | 1 | |
12/17/2020 | Series F | $350M | Undisclosed Investors | 5 | ||
10/12/2020 | Series E | |||||
5/9/2018 | Series D |
Date | 7/5/2022 | 2/25/2021 | 12/17/2020 | 10/12/2020 | 5/9/2018 |
|---|---|---|---|---|---|
Round | Series G | Series F - II | Series F | Series E | Series D |
Amount | $150M | $400M | $350M | ||
Investors | HongShan, Millennium Management, and Undisclosed Investors | Undisclosed Investors | |||
Valuation | $7,000M | ||||
Revenue | |||||
Sources | 3 | 1 | 5 |
We Doctor Deal Terms
3 Deal Terms
We Doctor's deal structure is available for 3 funding rounds, including their Series F - II from February 25, 2021.
Round | Series F - II | Series D | Series C |
|---|---|---|---|
Funding Date | |||
Pre-Money Valuation | |||
Post-Money Valuation | |||
Amount Raised | |||
Shares Authorized | |||
Issuance Price | |||
Dividend Rate | |||
Liquidation Preferences | |||
Liquidation Price | |||
Participation | |||
Conversion Price | |||
Anti Dilution | |||
General Voting | |||
Board Voting | |||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series F - II | |||||||||||||||
Series D | |||||||||||||||
Series C |
We Doctor Investors
18 Investors
We Doctor has 18 investors. Shandong Guotou invested in We Doctor's Series G funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
7/5/2022 | 7/5/2022 | 1 Series G | Private Equity | China | ||
3/18/2006 | 2/25/2021 | 3 Seed VC, Series C (2015), Series F - II (2021) | Venture Capital | China | ||
2/25/2021 | 2/25/2021 | 1 Series F - II | Diversified Financial Services | New York | ||
Asset/Investment Management | Bahrain | |||||
Venture Capital | China |
First funding | 7/5/2022 | 3/18/2006 | 2/25/2021 | ||
|---|---|---|---|---|---|
Last Funding | 7/5/2022 | 2/25/2021 | 2/25/2021 | ||
Investor | |||||
Rounds | 1 Series G | 3 Seed VC, Series C (2015), Series F - II (2021) | 1 Series F - II | ||
Board Seats | |||||
Type | Private Equity | Venture Capital | Diversified Financial Services | Asset/Investment Management | Venture Capital |
Location | China | China | New York | Bahrain | China |
We Doctor Acquisitions
2 Acquisitions
We Doctor acquired 2 companies. Their latest acquisition was Genea on August 31, 2018.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
8/31/2018 | Acq - Fin | 2 | ||||
1/30/2015 |
Date | 8/31/2018 | 1/30/2015 |
|---|---|---|
Investment Stage | ||
Companies | ||
Valuation | ||
Total Funding | ||
Note | Acq - Fin | |
Sources | 2 |
We Doctor Investments
4 Investments
We Doctor has made 4 investments. Their latest investment was in OrthoGuard as part of their Series A - II on December 27, 2021.
We Doctor Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
12/27/2021 | Series A - II | OrthoGuard | $3M | Yes | 5 | |
8/3/2018 | Corporate Minority | |||||
11/13/2017 | Series A | |||||
10/28/2016 | Corporate Minority |
Date | 12/27/2021 | 8/3/2018 | 11/13/2017 | 10/28/2016 |
|---|---|---|---|---|
Round | Series A - II | Corporate Minority | Series A | Corporate Minority |
Company | OrthoGuard | |||
Amount | $3M | |||
New? | Yes | |||
Co-Investors | ||||
Sources | 5 |
We Doctor Portfolio Exits
1 Portfolio Exit
We Doctor has 1 portfolio exit. Their latest portfolio exit was Wuzhen Internet Hospital on October 10, 2024.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
10/10/2024 | Divestiture | Wuzhen Internet Hospital | Acquirer | 1 |
Date | 10/10/2024 |
|---|---|
Exit | Divestiture |
Companies | Wuzhen Internet Hospital |
Valuation | |
Acquirer | Acquirer |
Sources | 1 |
Compare We Doctor to Competitors
Alodokter is a digital health company that provides mobile solutions for patients and doctors in the healthcare industry. The company offers a platform for online doctor bookings, a database of medical content, and facilitates patient-doctor interactions through its mobile application. Alodokter serves the healthcare sector by providing patients and doctors with access to medical services. Alodokter was formerly known as Ranelagh Pte. Ltd.. It was founded in 2014 and is based in Jakarta, Indonesia.
WeTherapy is a digital platform for the traditional Chinese medicine industry that allows individuals to connect to and engage with product and service providers across the traditional Chinese medicine ecosystem. WeTherapy's platform uses advanced analytics and AI to create individualized health solution bundles based on traditional Chinese Medicine theory to support individuals with the prevention of health issues and restoration to health after a health event.
Orion Five operates as a healthcare company through advanced artificial intelligence (AI). Its core offering is an AI-powered clinical assistant designed to provide healthcare professionals with evidence-based answers and insights. It primarily serves the healthcare sector. The company was founded in 2024 and is based in Harare, Zimbabwe.
SaudeHD provides healthcare management software for clinics and medical offices. Its offerings include electronic health records, automated patient scheduling, and integration with communication platforms like WhatsApp for appointment confirmations. The company serves the healthcare sector, providing tools for operations and patient care. It was founded in 2021 and is based in Fortaleza, Brazil.
Lemonilo operates in the consumer goods sector, focusing on food products that combine taste with natural ingredients. The company offers products aimed at providing options for a healthier lifestyle for Indonesians. Lemonilo primarily serves the consumer goods market, providing food options related to wellness. Lemonilo was formerly known as Konsula. It was founded in 2016 and is based in Jakarta, Indonesia.
HonestDocs is a health information platform that uses AI technology to provide healthcare content in various sectors. The company offers health information search, a library of healthcare content, and tools for interactions between patients and doctors. HonestDocs serves the healthcare industry with its AI-driven solutions. It was founded in 2019 and is based in Bangkok, Thailand.
Loading...